Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
14.07
-0.25 (-1.75%)
At close: Sep 11, 2026, 4:00 PM EDT
13.87
-0.20 (-1.42%)
After-hours: Sep 11, 2026, 7:39 PM EDT
Monte Rosa Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Maintains $28 | Buy | Maintains | $28 | +99.00% | Sep 9, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Reiterates $27 → $37 | Buy | Reiterates | $27 → $37 | +162.97% | Sep 9, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 8, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $27 | Buy | Maintains | $27 | +91.90% | Aug 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $37 | Buy | Reiterates | $37 | +162.97% | Aug 7, 2026 |
| Jefferies | Jefferies | Buy Maintains $25 | Buy | Maintains | $25 | +77.68% | Jul 31, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $29 | Buy | Reiterates | $29 | +106.11% | Jun 24, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 7, 2026 |